摘要
慢性乙型肝炎临床治愈已成为国内外公认的慢性乙型肝炎患者抗病毒治疗的理想目标,对临床治愈持久性和远期预后的关注也越来越多。本文针对慢性乙型肝炎患者临床治愈优势患者的选择、治疗策略选择及远期预后进行综述。
With the further development of clinical cure of chronic hepatitis B,it has gradually become an ideal target of antiviral therapy for patients with chronic hepatitis B at home and abroad.And there are more and more studies on clinical cure persistence and long-term prognosis.In this article,the choice of advantage patients with chronic hepatitis B,treatment strategy and long-term prognosis are reviewed.
作者
潘凡
黎环
潘晨
Pan Fan;Li Huan;Pan Chen(Hepatology Department,the 900th Hospital of Joint Logistics Support Force of PLA,Fuzhou 350000,China;Department of Hepatology,Mengchao Hepatobiliary Hospital of Fujian Medical University,Fujian Medical University,Fuzhou 350000,China)
出处
《国际流行病学传染病学杂志》
CAS
2021年第1期1-6,共6页
International Journal of Epidemiology and Infectious Disease
基金
福建省自然科学基金(2020J011136)。
关键词
肝炎
乙型
慢性
临床治愈
优势患者
联合治疗
Hepatitis B,chronic
Clinical cure
Dominant patients
Combination therapy
